Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (49,114) $ (33,803)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,139 1,204
Stock-based compensation expense 22,696 4,919
Provision for allowance for doubtful accounts 687 154
Amortization of costs capitalized to obtain revenue contracts 6,886 4,757
Changes in operating assets and liabilities:    
Accounts receivable 13,228 (7,323)
Costs capitalized to obtain revenue contracts (6,706) (8,969)
Prepaid expenses and other assets (2,734) (2,877)
Accounts payable (9) 366
Accrued liabilities (9,306) (1,769)
Contract liabilities 5,879 16,784
Other liabilities 86 552
Net cash used in operating activities (17,268) (26,005)
Cash flows from investing activities:    
Purchase of property and equipment (713) (1,955)
Purchase of intangible assets 0 (150)
Net cash used in investing activities (713) (2,105)
Cash flows from financing activities:    
Payment of offering costs (102) (4,025)
Payment of deferred purchase consideration 0 (1,766)
Proceeds from issuance of common stock upon exercise of stock options 2,244 1,822
Proceeds from issuance of common stock under the employee stock purchase plan 2,027 0
Net cash provided by (used in) financing activities 4,169 (3,969)
Net decrease in cash and cash equivalents (13,812) (32,079)
Cash and cash equivalents, beginning of period 178,430 96,972
Cash and cash equivalents, end of period 164,618 64,893
Supplemental disclosures of non-cash investing and financing activities:    
Purchases of property and equipment included in accounts payable and accrued liabilities 20 107
Offering costs in accrued liabilities $ 0 $ 1,151